Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
LY315920 is an inhibitor of human group IIA (hGIIA) secretory phospholipase A2 (sPLA2; IC50 = 9 nM).1 It also potently inhibits human GIIE and GX isoforms, as well as the corresponding mouse isoforms, but poorly inhibits other PLA2 enzymes.1,2,3,4 LY315920 inhibits sPLA2-induced release of thromboxane A2 from isolated guinea pig lung bronchoalveolar lavage cells (IC50 = 0.79 µM).2 Intravenous or oral administration of LY315920 to transgenic mice expressing human sPLA2 inhibits serum sPLA2 activity in a dose-related manner over four hours.2
WARNING This product is not for human or veterinary use.
1. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-
2. Pharmacology of LY315920/S-
3. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. J. Med. Chem. 51(15), 4708-4714 (2008).
4. Inhibition of the complete set of mammalian secreted phospholipases A2 by indole analogues: A structure-